|
Living Medical Textbook From Projects In Knowledge |
|
| Chapter 1 Chemotherapy in Recurrent or Metastatic Cervical Cancer |
| Chapter 2 Current Management of Endometrial Cancer |
| Chapter 3 Frontline Management of Ovarian Cancer |
| Chapter 4 Recurrent Ovarian Cancer Release date January 2009 |
| Chapter 5 Management of Early Breast Cancer Release date January 2009 |
| Chapter 6 Management of Advanced Breast Cancer Release date January 2009 |
| Table of Contents |
|
Chapter 3 - Frontline Management of Ovarian Cancer |
|
In chapter three of the Living Medical Textbook Women's Cancers Edition, Robert Morris, MD, focuses on detecting, diagnosing, and treating the disease early when enduring response is most likely. His expert opinion and review of the medical literature will help you to interpret early warning signs in your patients and to evaluate the role of frontline therapies, including standard-of-care intravenous and intraperitoneal chemotherapy, neoadjuvant and maintenance therapies, and emerging targeted agents.  top |
| |
|
Chapter 2 - Current Management of Endometrial Cancer |
|
Endometrial cancer is the most common gynecologic malignancy. Survival is high in localized disease, but drops dramatically when the disease spreads within or beyond the region. In chapter two of the Living Medical Textbook: Women's Cancers Edition, Thomas Herzog, MD, discusses prognostic factors and correlates risk of recurrence with adjuvant therapy recommendations based on clinical trial data. Join Dr. Herzog to better formulate current treatment regimens and anticipate developing therapies to improve outcomes for your patients with endometrial cancer. top |
| |
|
Chapter 1 - Chemotherapy in Recurrent or Metastatic Cervical Cancer |
|
Although the incidence of cervical cancer has declined in recent decades, the disease remains common enough to be routinely seen in the practices of oncology clinicians, gynecologists, and primary care physicians. In this first chapter of the Living Medical Textbook: Women's Cancers Edition, Bradley Monk, MD, provides framework of clinical trials in women with recurrent or metastatic cervical cancer that will help you to understand and formulate treatment options for your patients now, as well as to anticipate the potential role and survival impact of developing chemotherapy regimens and targeted therapies. top |
| |
|
Chapter 4 - Recurrent Ovarian Cancer Coming January 2009 |
|
In chapter four of the Living Medical Textbook: Women's Cancers Edition, Robert Coleman, MD, reviews current approaches to the treatment of women with recurrent ovarian cancer. Despite the devastating prognosis of recurrent disease, current and emerging therapies have much to offer in terms of disease control, maintenance of quality of life, and extended survival. Dr. Coleman’s focus on the significance of treatment-free interval and platinum-sensitivity status when choosing second-line therapy will help you select therapeutic regimens most likely to benefit your patients. In addition, his summary of emerging targeted agents and their performance in clinical trials of recurrent disease demonstrates future promising directions for therapy. top |
| |
|
Chapter 5 - Management of Early Breast Cancer Coming January 2009 |
|
Approximately one third of women with early stage breast cancer will eventually develop metastatic disease. Due to the poor prognosis of metastatic breast cancer and the inability to detect microscopic metastatic disease at the time of initial diagnosis, most patients are referred for adjuvant chemotherapy following local therapy. In chapter five of Living Medical Textbook: Women's Cancers Edition, Drs. Patrick Morris and Monica Fornier present strategies to identify patients most likely to benefit from adjuvant chemotherapy. Using genetic profiles, analysis of circulating tumor cells, and HER2 and BRCA1 and 2 testing, therapy for early breast cancer can be individualized based on each patient’s unique mix of risk factors. top |
| |
|
Chapter 6 - Management of Advanced Breast Cancer Coming January 2009 |
|
Treatment goals for advanced, recurrent, and metastatic breast cancer include prolonging survival and improving quality of life. In chapter six of Living Medical Textbook: Women's Cancers Edition, Drs. Patrick Morris and Monica Fornier evaluate current and emerging therapeutic approaches—including neoadjuvant and adjuvant cytotoxics, targeted agents, and novel therapeutics—within the context of the clinical challenges associated with progressive disease. top |
| |
|
| CME INFORMATION |
ACTIVITY GOAL |
| The goal of these CME activities is to examine current and emerging strategies for treating and managing patients with breast, ovarian, cervical and endometrial cancers. |
TARGET AUDIENCE |
| This series of activities is designed for medical oncology clinicians, gynecologists, primary care physicians and other clinicians who interact with and/or treat women with breast, ovarian, uterine/endometrial, and cervical cancers. |
LEARNING OBJECTIVES |
|
| top1863 |
|
|
|
|
|
These independent CME activities are supported by
educational grants from Bristol-Myers Squibb Company Genentech Inc. Novartis Pharmaceutical Corporation OrthoBiotech Inc. Pfizer Inc. |
|
| EDITORIAL BOARD | |
| CONTRIBUTING EDITOR Robert L. Coleman, MD |
|
|
Professor & Director of Clinical Research Department of Gynecologic Oncology University of Texas MD Anderson Cancer Center Houston, Texas |
| CONTRIBUTING EDITOR Thomas J. Herzog, MD |
|
|
Physicians & Surgeons Alumni Professor of Clinical Obstetrics and Gynecology Director Division of Gynecologic Oncology Columbia University College of Physicians & Surgeons New York, New York |
| CONTRIBUTING EDITOR Bradley J. Monk, MD |
|
|
Associate Professor Department of Obstetrics and Gynecology University of California, Irvine Orange, California |
| CONTRIBUTING EDITOR Robert T. Morris, MD |
|
|
Professor and Director Department of Gynecologic Oncology Wayne State University Detroit, Michigan |
| CONTRIBUTING EDITOR Patrick G. Morris, MD, MSc, MRCPI |
|
|
Special Fellow in Breast Medicine Breast Cancer Medicine Service Memorial Sloan-Kettering Cancer Center New York, New York |
